Format

Send to

Choose Destination
Data Brief. 2019 Jun 15;25:104118. doi: 10.1016/j.dib.2019.104118. eCollection 2019 Aug.

In vitro effects of resistin on epithelial to mesenchymal transition (EMT) in MCF-7 and MDA-MB-231 breast cancer cells - qRT-PCR and Westen blot analyses data.

Author information

1
Gerald J. Friedman Diabetes Institute at Lenox Hill Hospital, Northwell Health, New York, NY, USA.
2
The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, USA.
3
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.

Abstract

Resistin is an adipokine produced by the white adipocytes and adipose-derived macrophages, which mediates inflammation and insulin resistance Huang et al., 1997 and Renehan et al., 2008 Feb. Here, we provide data on the effect of resistin on epithelial to mesenchymal transition (EMT) in breast cancer cells in vitro. As model systems, we used human MCF-7 (low-metastatic) and MDA-MB-231 (high-metastatic) breast cancer cell lines. To optimize experimental conditions, we treated the cells with various concentrations of resistin (12.5, 25 and 50 ng/ml) for different time intervals (6 and 24 hours), and measured SOCS3 mRNA expression by using qRT-PCR analysis. Further, we used qRT-PCR and Western blot analyses to measure the expression of various epithelial (E-cadherin, claudin-1) and mesenchymal (SNAIL, SLUG, ZEB1, TWIST1, fibronectin, and vimentin) markers after resistin treatment. This data article is part of a study Avtanski et al., 2019 May, where detailed interpretation and discussion can be found.

KEYWORDS:

Breast cancer; Epithelial to mesenchymal transition (EMT); Resistin

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center